CAS 1293915-42-0

6-(2-((4-Amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide

CAS: 1293915-42-0

Formula: C₃₉H₃₉ClN₈O₅

Peso molecolare: 735.2306

Ref: IN-DA000Z3C

6-(2-((4-Amino-3-(3-hydroxyphenyl)-1H-pyrazolo(3,4-D)pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N -bis(2-methoxyethyl)hex-5-ynamide

CAS: 1293915-42-0

Cefuroxime is a broad-spectrum antibiotic that belongs to the group of antibiotics called cephalosporins. Cefuroxime acts by inhibiting bacterial cell wall synthesis and is effective against many Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. Cefuroxime is available in the form of an anhydrous, crystalline powder for oral administration. It has two stereoisomers, which are designated L-cefuroxime (L) and D-cefuroxime (D). The L form is more active than the D form. The L-form also has a higher yield in reactions with magnesium ions than the D form.

Formula: C₃₉H₃₉ClN₈O₅

Purezza: Min. 95%

Peso molecolare: 735.2 g/mol

Ref: 3D-TBC91542

RV-1729

CAS: 1293915-42-0

RV-1729, a phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) inhibitor, is used potentially for the treatment of asthma.

Formula: C₃₉H₃₉ClN₈O₅

Colore e forma: Solid

Peso molecolare: 735.23

Ref: TM-T28627